| Literature DB >> 20657440 |
Zining Cui1, Yun Ling, Baoju Li, Yongqiang Li, Changhui Rui, Jingrong Cui, Yanxia Shi, Xinling Yang.
Abstract
In order to find novel chitin synthesis inhibitors (CSIs) with good activity, benzoylphenylurea, a typical kind of CSIs, was chosen as the lead compound and 15 novel derivatives containing furan moieties were designed by converting the urea linkage of benzoylphenylureas into a semicarbazide and changing the aniline part into furoyl groups. The title compounds were synthesized by the reaction of substituted benzoyl isocyanates with 5-(substituted phenyl)-2-furoyl hydrazine, and the structures were confirmed by IR, (1)H-NMR, elemental analysis and single crystal X-ray diffraction analyses (compound E2). The bioassay results indicated that the title compounds exhibit good insecticidal activity, especially towards Plutella xylostella L., but had lower fungicidal activity. Inspiringly, the title compounds possessed obvious anticancer activity against human promyelocytic leukemic cell line (HL-60), and some of the title compounds also had activity against human hepatocellular carcinoma cell line (Bel-7402), human gastric carcinoma cell line (BGC-823), and human nasopharyngeal carcinoma cell line (KB). The results indicated that the linkage in the lead compounds was important to the bioactivity and spectra. The modification on the urea linkage is an effective strategy to discover new pesticide and drug candidates.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20657440 PMCID: PMC6257640 DOI: 10.3390/molecules15064267
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Design strategy for title compounds E.
Scheme 2General synthetic procedure for title compounds E.
Figure 1Molecular structure of compound E2, showing 30% probability ellipsoids, H atoms were shown as small spheres of arbitrary radii.
Crystal and experimental data of compound E2.
| Empirical formula | C19H12F3N3O4 |
| Formula weight | 403.32 |
| 173(2) K | |
| Wavelength | 1.54178 Å |
| Crystal system | Triclinic |
| Space group | |
| Unit cell dimensions | a = 6.8462(12) Å, |
| Volume | 844.4(3) Å3 |
| 2 | |
| 1.586 Mg/m3 | |
| Absorption coefficient | 1.171 mm-1 |
| 412 | |
| Crystal dimensions | 0.20 x 0.13 x 0.10 mm |
| 4.05 to 68.19 | |
| Completeness to | 96.7 % |
| Limiting indices | -8≤ |
| Reflection collected/unique | 8794/2990 [R(int) = 0.0529] |
| Absorption correction | Numerical |
| Max. and min. transmission | 0.8919 and 0.7995 |
| Data/restraints/parameters | 2990 / 0 / 263 |
| Goodness-of-fit on | 1.088 |
| Final | R1 = 0.0555, wR2 = 0.1218 |
| 2 | 136.38° with Cu |
| (Δ | 0.301 eÅ-3 |
| (Δ | -0.318 eÅ-3 |
| Program system | SHELXS-97, SHELXL-97 |
| Structure determination | Direct method |
| Refinement | Full-matrix least-squares on |
| CCDC No. | 769209 |
Selected bond lengths, angels, and torsion angles of compound E2.
| Lengths | (Å) | Angles | (°) | Torsion angles | (°) |
| C(4)-C(7) | 1.461(4) | O(2)-C(11)-N(1) | 123.0(3) | C(11)-N(1)-N(2)-C(12) | -113.9(3) |
| C(8)-C(11) | 1.470(4) | O(2)-C(11)-C(8) | 123.4(3) | C(6)-C(1)-C(2)-C(3) | 2.0(5) |
| C(13)-C(14) | 1.504(4) | O(3)-C(12)-N(3) | 119.9(3) | F(1)-C(1)-C(2)-C(3) | -177.7(3) |
| O(2)-C(11) | 1.228(3) | O(3)-C(12)-N(2) | 124.9(3) | C(5)-C(4)-C(7)-O(1) | 176.3(2) |
| O(3)-C(12) | 1.224(3) | O(4)-C(13)-C(14) | 120.6(3) | C(7)-O(1)-C(8)-C(9) | 0.0(3) |
| O(4)-C(13) | 1.219(3) | O(4)-C(13)-N(3) | 124.2(3) | N(2)-N(1)-C(11)-O(2) | 4.9(4) |
| N(1)-C(11) | 1.363(3) | N(2)-C(12)-N(3) | 115.2(2) | N(1)-N(2)-C(12)-O(3) | 4.1(4) |
| N(2)-C(12) | 1.342(3) | N(3)-C(13)-C(14) | 115.2(3) | N(1)-N(2)-C(12)-N(3) | -176.2(2) |
| N(3)-C(13) | 1.369(3) | C(13)-N(3)-C(12) | 127.7(2) | C(12)-N(3)-C(13)-O(4) | 6.4(4) |
| N(3)-C(12) | 1.398(3) | C(12)-N(2)-N(1) | 119.9(2) | O(4)-C(13)-C(14)-C(19) | 122.7(3) |
| N(1)-N(2) | 1.387(3) | C(11)-N(1)-N(2) | 118.4(2) | C(17)-C(18)-C(19)-F(3) | 179.9(3) |
The dihedral angles and the mean deviation of the planes in compound E2.
| Dihedral angles (°) | |
| Plane I and plane II | 4.2 |
| Plane I and plane III | 3.3 |
| Plane I and plane IV | 73.3 |
| Plane I and plane V | 17.5 |
| Plane II and plane III | 7.2 |
| Plane II and plane IV | 75.8 |
| Plane II and plane V | 19.9 |
| Plane III and plane IV | 70.1 |
| Plane III and plane V | 14.5 |
| plane IV and plane V | 55.9 |
| The mean deviation of the plane (Å) | |
| Plane I | 0.0099 |
| Plane II | 0.0009 |
| Plane III | 0.0144 |
| Plane IV | 0.0163 |
| Plane V | 0.0075 |
Fungicidal activity of compounds E against five fungus species at 50 μg mL-1.
| Compd. | Inhibitory rate (%) | ||||
| 1.94 | 13.61 | 7.50 | 0.00 | 2.22 | |
| 9.72 | 9.17 | 37.50 | 3.61 | 14.44 | |
| 22.50 | 6.11 | 29.17 | 1.39 | 8.33 | |
| 37.50 | 23.33 | 10.28 | 41.39 | 6.39 | |
| 23.61 | 54.72 | 32.22 | 0.00 | 8.06 | |
| 49.17 | 49.17 | 14.17 | 0.00 | 11.39 | |
| 8.89 | 29.17 | 5.83 | 0.00 | 5.83 | |
| 31.94 | 48.89 | 14.44 | 8.33 | 8.33 | |
| 10.28 | 28.61 | 28.89 | 0.56 | 10.28 | |
| 12.50 | 0.00 | 20.83 | 0.00 | 8.33 | |
| 19.44 | 0.00 | 9.72 | 50.00 | 6.94 | |
| 20.83 | 45.28 | 4.72 | 0.00 | 12.22 | |
| 13.06 | 4.17 | 8.61 | 0.00 | 19.72 | |
| 21.67 | 7.78 | 8.61 | 0.00 | 18.06 | |
| 4.17 | 10.56 | 30.28 | 0.00 | 5.00 | |
| 4.17 | 5.56 | 22.78 | 13.06 | 14.72 | |
| 86.39 a | 69.72 b | 68.33 c | 76.67 d | 68.61 e | |
aControl fungicides: a, 50% dimethomoph WP; b, 40% dimetachlone WP; c, 70% thiophanate-methyl WP; d, 3% jinggangmycin AS; e, 75%chlorothalonil WP
Insecticidal activity of compounds E at 500 μg mL-1.
| Compd. | Inhibitory rate (%) | ||
| 15.0 | 20.0 | 0 | |
| 32.0 | 20.0 | 0 | |
| 33.0 | 29.4 | 0 | |
| 30.0 | 17.1 | 0 | |
| 25.0 | 23.1 | 0 | |
| 20.0 | 12.9 | 0 | |
| 14.0 | 27.3 | 0 | |
| 24.0 | 32.7 | 0 | |
| 0 | 18.5 | 0 | |
| 95.0 | 15.4 | 0 | |
| 45.0 | 23.2 | 0 | |
| 16.0 | 19.2 | 0 | |
| 10.0 | 38.1 | 0 | |
| 0 | 24.5 | 0 | |
| 85.0 | 14.8 | 0 | |
| CK | 0 | 2.4 | 0 |
| Hexaflumuron | 100 | 22.6 | 100 |
| RH-5849 | 100 | 22.1 | 100 |
NT: not detected.
The IC50 values of antitumor activity of compounds E.
| Compd. | IC50 (mM) | |||
| HL-60 | Bel-7402 | BGC-823 | KB | |
| 1.56 | - | - | - | |
| 1.26 | - | - | - | |
| - | - | - | - | |
| - | - | - | - | |
| 0.13 | - | - | - | |
| - | - | - | - | |
| 11.99 | 5.39 | - | - | |
| - | - | - | - | |
| 5.39 | - | - | - | |
| - | - | - | - | |
| 0.44 | 11.02 | 1.42 | - | |
| 2.93 | - | - | - | |
| 0.18 | - | 59.46 | - | |
| 2.63 | - | - | - | |
| 0.14 | 0.36 | - | 0.09 | |
- means IC50 > 100 mM.